Early finerenone for heart failure in hospital
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if starting finerenone early helps patients hospitalized with heart failure who have symptoms like shortness of breath or swelling. It aims to see if the drug is safe and effective when given soon after admission.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the hospital for heart failure and need IV diuretics or vasodilators.
- You have new or worsening heart failure symptoms like shortness of breath, fatigue, or leg swelling.
- Your blood pressure is at least 100 mmHg and you are not in shock or on a breathing machine.
- Your heart function (LVEF) is 40% or higher from a test in the past year.
- You can take oral medication and have no planned dialysis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medication called finerenone to see if it helps people hospitalized for heart failure live longer and have fewer heart-related problems. It may be an option for those with a certain type of heart failure where the heart's pumping strength is mildly reduced or normal.
This trial tests a new medicine called finerenone to see if it can reduce heart scarring and improve heart function in people with a certain type of heart failure (preserved ejection fraction). If you qualify, you may help researchers learn if this treatment can help you feel better and stay out of the hospital.
This study tests whether finerenone, a new type of drug, can help people with heart failure who cannot take standard steroid-based MRAs (a kind of heart medication) because of side effects or other reasons. It aims to see if it improves symptoms and is safe for you.
This trial tests whether finerenone can improve heart muscle thickening in patients with certain heart or kidney risk factors. It may help reduce heart strain and improve heart function.
This study tests whether finerenone, a medication that may help the heart work better, can improve electrical stability in people with a certain type of heart failure (HFpEF). It aims to reduce irregular heart rhythms and improve overall heart health.
This study tests a new drug called finerenone to see if it can improve heart function in people with a type of heart failure where the heart pumps normally but is stiff. It may help reduce symptoms and improve quality of life.
Hear when a new Acute Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.